Characterizing PALB2 intragenic duplication breakpoints in a triple-negative breast cancer case using long-read sequencing - CRLC Val d'Aurelle - Paul Lamarque
Article Dans Une Revue Frontiers in Oncology Année : 2024

Characterizing PALB2 intragenic duplication breakpoints in a triple-negative breast cancer case using long-read sequencing

Résumé

Introduction : Accurate identification and characterization of Large Genomic Rearrangements (LGR), especially duplications, are crucial for precise diagnosis and risk assessment. In this report, we characterized an intragenic duplication breakpoint of PALB2 to determine its pathogenicity significance. Methods : A 52-year-old female with triple-negative breast cancer was diagnosed with a novel PALB2 LGR. An efficient and accurate methodology was applied, combining long-read sequencing and transcript analysis for the rapid characterization of the duplication. Results : Duplication of exons 5 and 6 of PALB2 was validated by transcript analysis. Long-read sequencing enabled the localization of breakpoints within Alu elements, providing insights into the mechanism of duplication via non-allelic homologous recombination. Conclusion Using our combined methodology, we reclassified the PALB2 duplication as a pathogenic variant. This reclassification suggests a possible causative link between this specific genetic alteration and the aggressive phenotype of the patient.
Fichier principal
Vignette du fichier
fonc-14-1355715.pdf (1.21 Mo) Télécharger le fichier
Vignette du fichier
Image 1.jpg (117.08 Ko) Télécharger le fichier
Vignette du fichier
Image 2.jpg (323.47 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
licence
Format Figure, Image
licence
Format Figure, Image
licence

Dates et versions

hal-04785069 , version 1 (15-11-2024)

Licence

Identifiants

Citer

Iulian Ban, Alice Chabert, Thomas Guignard, Jacques Puechberty, Simon Cabello-Aguilar, et al.. Characterizing PALB2 intragenic duplication breakpoints in a triple-negative breast cancer case using long-read sequencing. Frontiers in Oncology, 2024, 14, pp.7. ⟨10.3389/fonc.2024.1355715⟩. ⟨hal-04785069⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

More